Clinical Trials Logo

Clinical Trial Summary

The overall objective of this study is to develop an Augmentative and Alternative Communication (AAC) system that is effective in delivering a person-centric communication device that will provide a versatile access method that can automatically learn and adapt to the user's physical abilities by creating a personalized, comprehensive keyboard interface for communication, not otherwise available to people in need of alternative communication.


Clinical Trial Description

The investigators propose an AAC device comprising a versatile access method that automatically learns and customizes a keyboard interface to the residual motor function of the individual. The team comprising scientists, speech researchers and clinicians is developing a prototype AAC system comprising versatile access method and personalized, comprehensive communication software. This will be achieved by developing hardware to support streamlined access across multiple points on the body, designing automated algorithms to rapidly create an expanded AAC interface, inclusive of letters, numbers, symbols, emojis, and word completion options, that is personalized based on the residual motor function of user-specific access points, creating software for point-of-care use of the access technology and interface, and evaluating the resulting AAC system for communication efficacy in individuals with severe motor impairments. The milestone will be to demonstrate that our AAC system improves Information Transfer Rate (ITR) and user experience over conventional AAC devices. The final AAC deliverable will be easily integrated with existing AAC tablets and mobile devices to provide those in need of alternative communication methods with an automatically customized, efficient, and intuitive solution to restore communication access in their daily lives. The project's involvement of human subjects for the purpose of research is primarily focused on testing our AAC system for usability, improved performance, acceptance, and perceived benefit among individuals with severe motor impairments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06337188
Study type Interventional
Source Altec Inc.
Contact Bhawna Shiwani, M.S.
Phone 5085458217
Email bshiwani@altecresearch.com
Status Not yet recruiting
Phase N/A
Start date June 15, 2024
Completion date March 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT04377893 - Applying Eye-Gaze Assistive Technology for Children and Youth With Complex Needs N/A
Recruiting NCT06086951 - Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT N/A
Recruiting NCT05741853 - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia N/A
Recruiting NCT05872737 - FAB Programme for Parents of Children With NDD N/A
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Enrolling by invitation NCT05980897 - Inner Speech and Naming Treatment for Individuals With Aphasia N/A
Completed NCT01917864 - iPad Application to Treat Prosodic Deficits in Students With Communication Disorders N/A
Completed NCT00723151 - Effects of Intensity of Early Communication Intervention Phase 2
Completed NCT04247828 - Adaptive and Individualized AAC N/A
Completed NCT04655937 - Wellbeing After Stroke (WAterS): Supporting Adjustment and Wellbeing After Stroke Phase 1
Recruiting NCT02018614 - International Validation Study Of The Algoplus Scale In Five Languages N/A
Recruiting NCT06262646 - Video-conferencing FACT for Young Children With Special Needs N/A
Recruiting NCT04217460 - Intervention for Fluency Difficulty N/A
Completed NCT05398900 - Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires - Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children